retatrutide triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial THE EFFECT OF TRIPLE-HORMONE-RECEPTOR AGONIST

For women experiencing GLP-1 facial changes, these treatments may complement approaches that reach deeper collagen structures

Some people experience unpleasant side effects (e.g., nausea, constipation) that do not resolve over time, preventing its continued use

Originally developed to treat type 2 diabetes, GLP-1 medications are now widely prescribed for weight loss

Muscle phospholipid hydrolysis by Bothrops asper Asp49 and Lys49 phospholipase A2 myotoxins distinct mechanisms of action

The pill may appeal to people who are averse to needles, have dexterity limitations that make self-injecting challenging, or who travel or dont have easy access to refrigeration, which the injectables require

A practical approach for the 8mg and 12mg phases includes a protein shake in the morning (30 to 40 grams of protein), a small nutrient-dense meal at lunch, a protein-rich snack in the afternoon, and a balanced dinner focused on protein and vegetables